APA (7th ed.) Citation

M, F., V, G., CF, S., F, F., Z, B., R, G., . . . M, G. (2026). The Xpert Breast Cancer Insight Test Predicts Distant Recurrence and Overall Survival in ER-Positive, HER2-Negative Early Breast Cancer. Clinical breast cancer, 26(8), 112. https://doi.org/10.1016/j.clbc.2026.06.012

Chicago Style (17th ed.) Citation

M, Filipits, et al. "The Xpert Breast Cancer Insight Test Predicts Distant Recurrence and Overall Survival in ER-Positive, HER2-Negative Early Breast Cancer." Clinical Breast Cancer 26, no. 8 (2026): 112. https://doi.org/10.1016/j.clbc.2026.06.012.

MLA (9th ed.) Citation

M, Filipits, et al. "The Xpert Breast Cancer Insight Test Predicts Distant Recurrence and Overall Survival in ER-Positive, HER2-Negative Early Breast Cancer." Clinical Breast Cancer, vol. 26, no. 8, 2026, p. 112, https://doi.org/10.1016/j.clbc.2026.06.012.